1. AB0172 Protection from articular damage by passive or active anti-TNF alpha immunotherapy in human-TNF alpha transgenic mice depends on anti-TNF alpha antibody levels. (23rd January 2014) Authors: Semerano, L.; Biton, J.; Delavallee, L.; Duvallet, E.; Assier, E.; Bessis, N.; Bernier, E.; Dhellin, O.; Grouard-Vogel, G.; Boissier, M.-C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0152 Active therapeutic immunization with TNF-kinoid in rheumatoid arthritis patients with secondary resistance to tnfα antagonists is safe and immunogenic. (23rd January 2014) Authors: Durez, P.; Miranda, P.; Toncheva, A.; Berman, A.; Rillo, O.L.; Boutsen, Y.; Kehler, T.; Mociran, E.; Soto Saez, L.; Fautrel, B.; Mariette, X.; Sokalov, P.; Lucero, E.; Vlak, T.; Grazio, S.; Mastrovic, K.; Chirieac, R.; Grouard-Vogel, G.; Dhellin, O.; Ouary, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels. (11th March 2013) Authors: Semerano, L.; Biton, J.; Delavallée, L.; Duvallet, E.; Assier, E.; Bessis, N.; Bernier, E.; Dhellin, O.; Grouard‐Vogel, G.; Boissier, M.‐C. Journal: Clinical and experimental immunology Issue: Volume 172:Number 1(2013:Apr.) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗